✦ LIBER ✦

The PPARδ agonist GW0742X reduces atherosclerosis in LDLR−/− mice

✍ Scribed by Tracey L. Graham; Claudette Mookherjee; Keith E. Suckling; Colin N. A. Palmer; Lisa Patel

Book ID: 118420638
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 376 KB
Volume: 181
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2004.12.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “The PPARδ agonist GW0742

Corrigendum to “The PPARδ agonist GW0742X reduces atherosclerosis in LDLR−/− mice” [Atherosclerosis 181 (2005) 29–37]

✍ Tracey L. Graham; Claudette Mookherjee; Keith E. Suckling; Colin N.A. Palmer; Li 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

W01.115 GW0742X, a potent and selective

W01.115 GW0742X, a potent and selective PPARδ ligand, inhibits the development of atherosclerosis in LDLR knockout mice

✍ Graham, T.L.; Palmer, C.N.A.; Patel, L. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Abstract: P984 PPAR Δ AGONIST GW501516 S

Abstract: P984 PPAR Δ AGONIST GW501516 STRONGLY PREVENTS DEVELOPMENT OF ATHEROSCLEROSIS IN APOE*3LEIDEN MICE

✍ van der Hoorn, J; van Den Hoogen, C; Pieterman, E; Princen, H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Both the Peroxisome Proliferator-Activat

Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol

✍ François Briand; Snehal U. Naik; Ilia Fuki; John S. Millar; Colin Macphee; Max W 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 527 KB

Atherosclerosis in LDLR-Knockout Mice Is

Atherosclerosis in LDLR-Knockout Mice Is Inhibited, but Not Reversed, by the PPARγ Ligand Pioglitazone

✍ Hideaki Nakaya; Barbara D. Summers; Andrew C. Nicholson; Antonio M. Gotto Jr.; D 📂 Article 📅 2009 🏛 American Society for Investigative Pathology 🌐 English ⚖ 431 KB

The dual PPARα/γ agonist tesaglitazar bl

The dual PPARα/γ agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice

✍ JWA Van Der Hoorn; JW Jukema; LM Havekes; E Lundholm; G Camejo; PCN Rensen; HMG 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB